Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995) (Q33758413)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995) |
scientific article |
Statements
1 reference
Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995) (English)
1 reference
Martin S Tallman
1 reference
Elisabeth Paietta
1 reference
Ranjana Advani
1 reference
Branimir I Sikic
1 reference
Peter L Greenberg
1 reference
Sandra J Lee
1 reference
Louis Letendre
1 reference
Kathleen Dugan
1 reference
Bert Lum
1 reference
David L Chin
1 reference
Gordon Dewald
1 reference
John M Bennett
1 reference
Jacob M Rowe
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference